BioLineRx Investor Relations Material
Latest events
Q2 2024
BioLineRx
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from BioLineRx Ltd
Access all reports
BioLineRx Ltd. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapeutics for oncology and rare diseases. The company's primary product pipeline includes therapies aimed at treating multiple myeloma, sickle cell disease, pancreatic cancer, and other solid tumors. BioLineRx leverages extensive drug development expertise to advance these therapies from preclinical stages through to commercialization. The company is headquartered in Hevel Modi'in, Israel, and its shares are listed on the NASDAQ.
Latest articles
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Irwin Jacobs & Andrew Viterbi: Qualcomm's Pioneering Founders
In 1985, Irwin Jacobs and Andrew Viterbi co-founded Qualcomm, a leading company in telecommunications and semiconductor innovation.
3 Oct 2024
Ticker symbol
BLRX
Country
🇺🇸 United States